🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will study a prime-boost vaccine approach designed mainly to ind...
Status
Completed
Location
St Stephen's Centre Chelsea and Westminster Hospital
Start Date
2008-11
Trial ID
NCT00902824
The goal of this multi-center, randomized, double-blind, placebo-controlled...
Status
Recruiting
Location
ARK Clinical Research, LLC
Start Date
2025-06-05
Trial ID
NCT07003984
Treatments Being Tested
This study is the first administration of GSK2798745 in humans. This will b...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-09
Trial ID
NCT02119260
1. Eosinophilic asthma, a type 2 immune disorder, often involves the excess...
Status
Not Yet Recruiting
Location
Advagene Biopharma
Start Date
2025-12
Trial ID
NCT07250594
Treatments Being Tested
The purpose of this study is to rank different RSV vaccine dosages of antig...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-11-10
Trial ID
NCT02956837
The primary objective is to assess the safety and tolerability of two conse...
Status
Completed
Location
MUHC Vaccine Study Centre
Start Date
2009-09
Trial ID
NCT00984945
This is a Phase 1, randomized, double-blind, placebo-controlled, single asc...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-07-11
Trial ID
NCT02860715
The purpose of this study is to determine whether ARA 290, a new class of c...
Status
Completed
Location
Cleveland Clinic
Start Date
2014-01
Trial ID
NCT02039687
The primary objective of the study is to evaluate the safety of UX053 in ad...
Status
Terminated
Location
University of California, Irvine
Start Date
2021-10-18
Trial ID
NCT04990388
Treatments Being Tested
This is a randomized, placebo-controlled, single ascending dose (SAD) study...
Status
Recruiting
Location
Rocky Mountain Clinical Research
Start Date
2026-02-01
Trial ID
NCT07422675
Treatments Being Tested